The global Sex Hormone Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The driving factors for sex hormone drugs mainly include the following aspects:
Disease treatment needs: Sex hormone drugs are mainly used to treat sexual dysfunction, infertility, menopausal syndrome and other diseases. These diseases have a great impact on patients' physical and mental health, so sex hormone drugs are needed to relieve symptoms and improve quality of life.
Aging of the population: As the aging of the population intensifies, the incidence of age-related diseases such as menopausal syndrome is gradually increasing, which has further promoted the development of the sex hormone drug market.
Increased awareness of self-care: As people pay more and more attention to health and self-care, more and more people are paying attention to their physical conditions and taking measures for prevention and treatment. As an effective health care method, sex hormone drugs have attracted more and more people's attention and recognition.
Progress in drug research and development: With the continuous advancement of science and technology, the research and development of sex hormone drugs is also making continuous progress. The emergence of new varieties and new dosage forms provides patients with more choices and better treatment effects, and further promotes the development of the sex hormone drug market.
Improvement of the medical security system: With the continuous improvement of the global medical security system, people can obtain sex hormone drugs more conveniently, which also provides favorable conditions for the development of the sex hormone drug market.
This report aims to provide a comprehensive presentation of the global market for Sex Hormone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sex Hormone Drugs.
Report Scope
The Sex Hormone Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sex Hormone Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sex Hormone Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Pfizer
Teva Pharmaceuticals
Bayer
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Kingyork Group
Guangzhou Baiyunshan Mingxing Pharmaceutical
Segment by Type
Progestins
Male Hormones
Estrogens
Segment by Application
Hospital Clinic
Pharmacy
Online Mall
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sex Hormone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sex Hormone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Sex Hormone Drugs 麻豆原创 Overview
1.1 Product Overview and Scope of Sex Hormone Drugs
1.2 Sex Hormone Drugs Segment by Type
1.2.1 Global Sex Hormone Drugs 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Progestins
1.2.3 Male Hormones
1.2.4 Estrogens
1.3 Sex Hormone Drugs Segment by Application
1.3.1 Global Sex Hormone Drugs 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Online Mall
1.4 Global Sex Hormone Drugs 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Sex Hormone Drugs Revenue 2019-2030
1.4.2 Global Sex Hormone Drugs Sales 2019-2030
1.4.3 Global Sex Hormone Drugs 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sex Hormone Drugs 麻豆原创 Competition by Manufacturers
2.1 Global Sex Hormone Drugs Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Sex Hormone Drugs Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Sex Hormone Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Sex Hormone Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sex Hormone Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sex Hormone Drugs, Product Type & Application
2.7 Sex Hormone Drugs 麻豆原创 Competitive Situation and Trends
2.7.1 Sex Hormone Drugs 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sex Hormone Drugs Players 麻豆原创 Share by Revenue
2.7.3 Global Sex Hormone Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sex Hormone Drugs Retrospective 麻豆原创 Scenario by Region
3.1 Global Sex Hormone Drugs 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sex Hormone Drugs Global Sex Hormone Drugs Sales by Region: 2019-2030
3.2.1 Global Sex Hormone Drugs Sales by Region: 2019-2024
3.2.2 Global Sex Hormone Drugs Sales by Region: 2025-2030
3.3 Global Sex Hormone Drugs Global Sex Hormone Drugs Revenue by Region: 2019-2030
3.3.1 Global Sex Hormone Drugs Revenue by Region: 2019-2024
3.3.2 Global Sex Hormone Drugs Revenue by Region: 2025-2030
3.4 North America Sex Hormone Drugs 麻豆原创 Facts & Figures by Country
3.4.1 North America Sex Hormone Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sex Hormone Drugs Sales by Country (2019-2030)
3.4.3 North America Sex Hormone Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sex Hormone Drugs 麻豆原创 Facts & Figures by Country
3.5.1 Europe Sex Hormone Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sex Hormone Drugs Sales by Country (2019-2030)
3.5.3 Europe Sex Hormone Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sex Hormone Drugs 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Sex Hormone Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sex Hormone Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Sex Hormone Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sex Hormone Drugs 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Sex Hormone Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sex Hormone Drugs Sales by Country (2019-2030)
3.7.3 Latin America Sex Hormone Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sex Hormone Drugs 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Sex Hormone Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sex Hormone Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sex Hormone Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sex Hormone Drugs Sales by Type (2019-2030)
4.1.1 Global Sex Hormone Drugs Sales by Type (2019-2024)
4.1.2 Global Sex Hormone Drugs Sales by Type (2025-2030)
4.1.3 Global Sex Hormone Drugs Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Sex Hormone Drugs Revenue by Type (2019-2030)
4.2.1 Global Sex Hormone Drugs Revenue by Type (2019-2024)
4.2.2 Global Sex Hormone Drugs Revenue by Type (2025-2030)
4.2.3 Global Sex Hormone Drugs Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Sex Hormone Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sex Hormone Drugs Sales by Application (2019-2030)
5.1.1 Global Sex Hormone Drugs Sales by Application (2019-2024)
5.1.2 Global Sex Hormone Drugs Sales by Application (2025-2030)
5.1.3 Global Sex Hormone Drugs Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Sex Hormone Drugs Revenue by Application (2019-2030)
5.2.1 Global Sex Hormone Drugs Revenue by Application (2019-2024)
5.2.2 Global Sex Hormone Drugs Revenue by Application (2025-2030)
5.2.3 Global Sex Hormone Drugs Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Sex Hormone Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Sex Hormone Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Sex Hormone Drugs Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Sex Hormone Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Sex Hormone Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Teva Generics
6.5.1 Teva Generics Corporation Information
6.5.2 Teva Generics Description and Business Overview
6.5.3 Teva Generics Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Generics Sex Hormone Drugs Product Portfolio
6.5.5 Teva Generics Recent Developments/Updates
6.6 Besins Healthcare
6.6.1 Besins Healthcare Corporation Information
6.6.2 Besins Healthcare Description and Business Overview
6.6.3 Besins Healthcare Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Besins Healthcare Sex Hormone Drugs Product Portfolio
6.6.5 Besins Healthcare Recent Developments/Updates
6.7 Virtus Pharmaceuticals, LLC
6.6.1 Virtus Pharmaceuticals, LLC Corporation Information
6.6.2 Virtus Pharmaceuticals, LLC Description and Business Overview
6.6.3 Virtus Pharmaceuticals, LLC Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Virtus Pharmaceuticals, LLC Sex Hormone Drugs Product Portfolio
6.7.5 Virtus Pharmaceuticals, LLC Recent Developments/Updates
6.8 BionPharma
6.8.1 BionPharma Corporation Information
6.8.2 BionPharma Description and Business Overview
6.8.3 BionPharma Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BionPharma Sex Hormone Drugs Product Portfolio
6.8.5 BionPharma Recent Developments/Updates
6.9 Aquatic Remedies
6.9.1 Aquatic Remedies Corporation Information
6.9.2 Aquatic Remedies Description and Business Overview
6.9.3 Aquatic Remedies Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aquatic Remedies Sex Hormone Drugs Product Portfolio
6.9.5 Aquatic Remedies Recent Developments/Updates
6.10 Xianju Pharmaceutical
6.10.1 Xianju Pharmaceutical Corporation Information
6.10.2 Xianju Pharmaceutical Description and Business Overview
6.10.3 Xianju Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xianju Pharmaceutical Sex Hormone Drugs Product Portfolio
6.10.5 Xianju Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Aisheng Pharmaceutical
6.11.1 Zhejiang Aisheng Pharmaceutical Corporation Information
6.11.2 Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Description and Business Overview
6.11.3 Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Product Portfolio
6.11.5 Zhejiang Aisheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Medicine
6.12.1 Zhejiang Medicine Corporation Information
6.12.2 Zhejiang Medicine Sex Hormone Drugs Description and Business Overview
6.12.3 Zhejiang Medicine Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Medicine Sex Hormone Drugs Product Portfolio
6.12.5 Zhejiang Medicine Recent Developments/Updates
6.13 Hubei Dongxin Pharmaceutical
6.13.1 Hubei Dongxin Pharmaceutical Corporation Information
6.13.2 Hubei Dongxin Pharmaceutical Sex Hormone Drugs Description and Business Overview
6.13.3 Hubei Dongxin Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hubei Dongxin Pharmaceutical Sex Hormone Drugs Product Portfolio
6.13.5 Hubei Dongxin Pharmaceutical Recent Developments/Updates
6.14 Tianjin Kingyork Group
6.14.1 Tianjin Kingyork Group Corporation Information
6.14.2 Tianjin Kingyork Group Sex Hormone Drugs Description and Business Overview
6.14.3 Tianjin Kingyork Group Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tianjin Kingyork Group Sex Hormone Drugs Product Portfolio
6.14.5 Tianjin Kingyork Group Recent Developments/Updates
6.15 Guangzhou Baiyunshan Mingxing Pharmaceutical
6.15.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Corporation Information
6.15.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Description and Business Overview
6.15.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Product Portfolio
6.15.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sex Hormone Drugs Industry Chain Analysis
7.2 Sex Hormone Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sex Hormone Drugs Production Mode & Process
7.4 Sex Hormone Drugs Sales and 麻豆原创ing
7.4.1 Sex Hormone Drugs Sales Channels
7.4.2 Sex Hormone Drugs Distributors
7.5 Sex Hormone Drugs Customers
8 Sex Hormone Drugs 麻豆原创 Dynamics
8.1 Sex Hormone Drugs Industry Trends
8.2 Sex Hormone Drugs 麻豆原创 Drivers
8.3 Sex Hormone Drugs 麻豆原创 Challenges
8.4 Sex Hormone Drugs 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pfizer
Teva Pharmaceuticals
Bayer
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Kingyork Group
Guangzhou Baiyunshan Mingxing Pharmaceutical
听
听
*If Applicable.